HIV and proteinuria in an injection drug user population

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 10, 2010, Pages 1836-1843

  Yanik, Elizabeth L ^a   Lucas, Gregory M ^b   Vlahov, David ^c   Kirk, Gregory D ^b,d   Mehta, Shruti H ^d  

^a IL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EMPLOYMENT STATUS; FEMALE; HEALTH INSURANCE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PROTEIN URINE LEVEL; PROTEINURIA; URINALYSIS;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BALTIMORE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; DRUG USERS; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROTEINURIA; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD; YOUNG ADULT;

EID: 77958608030     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01030210     Document Type: Article

References (30)

1. Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B: Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis 47: 1449-1457, 2008
2. Deeks SG, Phillips AN: HIV Infection, antiretroviral treatment, aging, and non-AIDS related morbidity. BMJ 338: 288-292, 2009
3. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriquez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA: Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40: 1559-1585, 2005
4. Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA: Spectrum of chronic kidney disease in HIV-infected patients. HIV Med 10: 329-336, 2009
5. Fine DM, Garg N, Haas M, Rahman MH, Lucas GM, Scheel PJ, Atta MG: Cocaine use and hypertensive renal changes in HIV-infected individuals. Clin J Am Soc Nephrol 2: 1125-1130, 2007
6. Jaffe JA, Kimmel PL: Chronic nephropathies of cocaine and heroin abuse: A critical review. Clin J Am Soc Nephrol 1: 655-667, 2006
7. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson Ke, Celantano DD, Solomon L, Polk BF: The ALIVE Study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. NIDA Res Monogr 109: 75-100, 1991 (Pubitemid 23095616)
8. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254, 2006 (Pubitemid 46768608)
9. National Kidney Foundation: KDOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39 [suppl 1]: S1-S000, 2002
10. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving H-H, Steffes MW, Toto R: Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK). Am J Kidney Dis 42: 617-622, 2003 (Pubitemid 37187362)
11. Barros AJD, Hirakata VN: Alternatives to logistic regression in cross-sectional studies: An empirical comparison of model that directly estimate the prevalence ratio. BMC Med Res Methodol 3: 21, 2003
12. Ritz E: Proteinuria and vascular damage - The vicious twins. N Engl J Med 348: 2349-2352, 2003
13. De Lorenzo F, Collot-Teixeira S, Boffito M, Feher M, Gazzard B, McGregor JL: Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: Rationale for preventative measures. Curr Med Chem 15: 2991-2999, 2008
14. Rhee MS, Schmid CH, Stevens LA, Forrester JE: Risk factors for proteinuria in HIV-infected and -uninfected Hispanic drug users. Am J Kidney Dis 52: 683-690, 2008
15. Wyatt CM, Malvestutto C, Coca SG, Klotman PE, Parikh CR: The impact of hepatitis C virus co-infection on HIV-related kidney disease: A systematic review and metaanalysis. AIDS 22: 1799-1807, 2008
16. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007 (Pubitemid 350074801)
17. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int 61: 2165-2175, 2002
18. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303: 423-429, 2010
19. Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD: End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 21: 2435-2443, 2007
20. Overton ET, Nurutidinova D, Freeman J, Seyfried W, Mondy KE: Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med 10: 343-350, 2009
21. Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG: Cystatin C Level as a Marker of Kidney Function in Human Immunodefiency Virus Infection. Arch Intern Med 167: 2213-2219, 2007 (Pubitemid 350106741)
22. Szczech LA, Grunfeld C, Scherzer R, Canchola JA, van der Horst C, Sidney S, Wohl D, Shlipak MG: Microalbuminuria in HIV infection. AIDS 21: 1003-1009, 2007
23. Szczech LA, Menezes P, Quinlivan EB, van der Horst C, Bartlett JA, Svetkey LP: Microalbuminaria predicts overt proteinuria among patients with HIV infection. HIV Med January 4, 2010 [epub ahead of print]
24. Bakir AA, Dunea G: Drugs of abuse and renal disease. Curr Opin Nephrol Hypertens 5: 122-126, 1996
25. Bemanian S, Motallebi M, Nosrati SM: Cocaine-induced renal infarction: Report of a case and review of the literature. BMC Nephrol 6: 10, 2005 (Pubitemid 41454719)
26. Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD: Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: Description and determinants. Am J Epidemiol 158: 695-704, 2003
27. Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM: Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis 45: 1625-1632, 2007
28. Stevens LA, Levey AS: Measurement of kidney function. Med Clin North Am 89: 457-473, 2005
29. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003 (Pubitemid 36043346)
30. Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D: Risk behaviors by audio computer-assisted selfinterviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev 14: 367-378, 2002 (Pubitemid 35204858)